A myeloma survivor in long remission shares how research, expert care and advocacy turned fear into hope as more patients ...

Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...

Success is no longer just about prolonging survival, but about enabling patients to live well after cancer, with fewer ...

Cancer survival reaches 70% at 5 years, as targeted and immunotherapies boost outcomes and shift care toward survivorship and long-term quality of life.

She’s a local legend, and at 84, she’s only getting better. Ellen Hart, the larger-than-life owner of Broadway’s iconic Ellen ...

India’s cancer pattern has shifted, with breast cancer now most common. Experts link rising cases to lifestyle changes, ...

CAR-T treatment landscape in multiple myeloma basically has changed dramatically over the past few years.

This is a great question. So I personally think that CAR T-cell therapies, they do have a meaningful positive impact on quality of life for many myeloma patients, particularly after recovery from the ...

The 'Grey's Anatomy' star died on Thursday, Feb. 19, less than a year after being diagnosed with the disease ...

Patients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.